<DOC>
	<DOCNO>NCT00004178</DOCNO>
	<brief_summary>RATIONALE : Inserting gene create laboratory person 's white blood cell may make body build immune response kill cancer cell . PURPOSE : Phase I trial study effectiveness gene therapy treat patient cancer respond previous therapy .</brief_summary>
	<brief_title>Gene Therapy Treating Patients With Cancer</brief_title>
	<detailed_description>OBJECTIVES : - Determine safety maximum tolerate dose T cell activate vitro modify chimeric anti-CEA immunoglobulin T cell receptor ( Ig TCR ) patient CEA express adenocarcinoma . - Determine pharmacokinetics regimen persistence modify T cell blood patient . - Evaluate immunogenicity murine sequence chimeric anti-CEA Ig TCR . - Assess immunologic parameter correlate efficacy regimen patient . - Evaluate , preliminary manner , efficacy regimen patient CEA bearing tumor . OUTLINE : This dose escalation study . Peripheral blood lymphocyte ( PBL ) harvest . PBL activate vitro modify recombinant chimeric anti-CEA immunoglobulin T cell receptor ( Ig TCR ) . Ig TCR modify T cell reinfused 30-60 minute . The estimated maximum tolerate dose ( MTD ) define dose 2 6 patient experience unacceptable toxicity . If MTD reach within first cohort , second cohort 3 patient receive 4 dos modify T cell higher dose . Patients follow every 2 week 2 month . PROJECTED ACCRUAL : A total 6-9 patient accrue study .</detailed_description>
	<mesh_term>Adenocarcinoma</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically prove CEA express adenocarcinoma Serum CEA level great 10 ng/mL Failed standard therapy Measurable disease PATIENT CHARACTERISTICS : Age : 18 Performance status : 02 Life expectancy : Greater 2 month Hematopoietic : Not specify Hepatic : No significant hepatic disease Bilirubin great 3 mg/dL No active clinical disease cause hepatitis B Renal : No significant renal disease Creatinine great 3 mg/dL Cardiovascular : No significant cardiovascular disease Pulmonary : No significant pulmonary disease Other : Not pregnant Negative pregnancy test Fertile patient must use effective contraception No significant endocrine , rheumatologic , allergic disease No active clinical disease cause cytomegalovirus tuberculosis HIV negative PRIOR CONCURRENT THERAPY : Biologic therapy : Not specify Chemotherapy : At least 4 week since prior chemotherapy Endocrine therapy : Not specify Radiotherapy : At least 4 week since prior radiotherapy Surgery : Not specify</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2006</verification_date>
	<keyword>stage III colon cancer</keyword>
	<keyword>stage IV colon cancer</keyword>
	<keyword>stage III gastric cancer</keyword>
	<keyword>stage IV gastric cancer</keyword>
	<keyword>recurrent gastric cancer</keyword>
	<keyword>recurrent non-small cell lung cancer</keyword>
	<keyword>stage II pancreatic cancer</keyword>
	<keyword>stage III pancreatic cancer</keyword>
	<keyword>recurrent pancreatic cancer</keyword>
	<keyword>stage III rectal cancer</keyword>
	<keyword>stage IV rectal cancer</keyword>
	<keyword>recurrent colon cancer</keyword>
	<keyword>recurrent rectal cancer</keyword>
	<keyword>stage II esophageal cancer</keyword>
	<keyword>stage III esophageal cancer</keyword>
	<keyword>stage IV esophageal cancer</keyword>
	<keyword>recurrent esophageal cancer</keyword>
	<keyword>stage III cervical cancer</keyword>
	<keyword>recurrent cervical cancer</keyword>
	<keyword>stage IVB cervical cancer</keyword>
	<keyword>stage IVA cervical cancer</keyword>
	<keyword>adenocarcinoma prostate</keyword>
	<keyword>stage III renal cell cancer</keyword>
	<keyword>stage IV renal cell cancer</keyword>
	<keyword>recurrent renal cell cancer</keyword>
	<keyword>stage III ovarian epithelial cancer</keyword>
	<keyword>stage IV ovarian epithelial cancer</keyword>
	<keyword>recurrent ovarian epithelial cancer</keyword>
	<keyword>adenocarcinoma stomach</keyword>
	<keyword>extensive stage small cell lung cancer</keyword>
	<keyword>recurrent small cell lung cancer</keyword>
	<keyword>stage III vaginal cancer</keyword>
	<keyword>stage IVA vaginal cancer</keyword>
	<keyword>stage IVB vaginal cancer</keyword>
	<keyword>recurrent vaginal cancer</keyword>
	<keyword>localize unresectable adult primary liver cancer</keyword>
	<keyword>advanced adult primary liver cancer</keyword>
	<keyword>recurrent adult primary liver cancer</keyword>
	<keyword>stage III endometrial carcinoma</keyword>
	<keyword>stage IV endometrial carcinoma</keyword>
	<keyword>recurrent endometrial carcinoma</keyword>
	<keyword>small intestine adenocarcinoma</keyword>
	<keyword>unresectable gallbladder cancer</keyword>
	<keyword>recurrent gallbladder cancer</keyword>
	<keyword>unresectable extrahepatic bile duct cancer</keyword>
	<keyword>recurrent extrahepatic bile duct cancer</keyword>
	<keyword>recurrent small intestine cancer</keyword>
	<keyword>stage III bladder cancer</keyword>
	<keyword>recurrent bladder cancer</keyword>
	<keyword>stage IV bladder cancer</keyword>
	<keyword>stage III prostate cancer</keyword>
	<keyword>stage IV prostate cancer</keyword>
	<keyword>recurrent prostate cancer</keyword>
	<keyword>stage IV non-small cell lung cancer</keyword>
	<keyword>stage III salivary gland cancer</keyword>
	<keyword>stage IV salivary gland cancer</keyword>
	<keyword>recurrent salivary gland cancer</keyword>
	<keyword>duct cell adenocarcinoma pancreas</keyword>
	<keyword>ovarian undifferentiated adenocarcinoma</keyword>
	<keyword>adenocarcinoma lung</keyword>
	<keyword>adenocarcinoma esophagus</keyword>
	<keyword>intestinal adenocarcinoma stomach</keyword>
	<keyword>adenocarcinoma colon</keyword>
	<keyword>diffuse adenocarcinoma stomach</keyword>
	<keyword>mixed adenocarcinoma stomach</keyword>
	<keyword>mucinous adenocarcinoma colon</keyword>
	<keyword>signet ring adenocarcinoma colon</keyword>
	<keyword>adenocarcinoma rectum</keyword>
	<keyword>adenocarcinoma gallbladder</keyword>
	<keyword>mucinous adenocarcinoma rectum</keyword>
	<keyword>signet ring adenocarcinoma rectum</keyword>
	<keyword>adenocarcinoma squamous metaplasia gallbladder</keyword>
	<keyword>adenocarcinoma extrahepatic bile duct</keyword>
	<keyword>ovarian serous cystadenocarcinoma</keyword>
	<keyword>ovarian mucinous cystadenocarcinoma</keyword>
	<keyword>ovarian endometrioid adenocarcinoma</keyword>
	<keyword>ovarian clear cell cystadenocarcinoma</keyword>
	<keyword>vaginal adenocarcinoma</keyword>
	<keyword>vaginal clear cell adenocarcinoma</keyword>
	<keyword>endometrial adenocarcinoma</keyword>
	<keyword>cervical adenocarcinoma</keyword>
	<keyword>adenocarcinoma bladder</keyword>
	<keyword>salivary gland adenocarcinoma</keyword>
	<keyword>adenocarcinoma unknown primary</keyword>
	<keyword>adenocarcinoma pancreas</keyword>
	<keyword>stage IV pancreatic cancer</keyword>
</DOC>